Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Bilbao Vizcaya Argentaria SA vs Sana Biotechnology Inc — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.6 (market cap $157.51B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 139.4× Sana Biotechnology Inc's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 3.8% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| BBVA | SANA | |
|---|---|---|
Market Cap | $157.51B | $1.13B |
Sector | Financials | Health |
52-Week High | $28.50 | $5.92 |
52-Week Low | $17.96 | $2.68 |
Dividend Yield | 3.8% | — |
Enterprise Value | — | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
